Status:
ACTIVE_NOT_RECRUITING
Moving Well for Total Knee Arthroplasty (TKA)
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Rheumatology Research Foundation
Hospital for Special Surgery, New York
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the efficacy of a behavioral intervention, Moving Well, in improving levels of anxiety and depression for patients undergoing total knee arthroplasty (TKA).
Detailed Description
Moving Well is a behavioral intervention, guided by peer coaches, that aims to improve mental and physical preparation for patients planning to undergo total knee arthroplasty (TKA) and improve postop...
Eligibility Criteria
Inclusion
- Subjects must have their primary TKR (one knee or both knees) scheduled in 8 weeks or more
- Be willing to participate in the Moving Well (intervention) arm or Staying Well (attention control) arm
- Are willing to work with a coach
- ≥ 50 years of age
- Speak English
- Have access to the internet, computer, and a working phone
- We will prioritize the recruitment of subjects with low socioeconomic status defined as being a beneficiary of Medicaid or no insurance and an underrepresented racial/ethnic group (Hispanic/Black).
Exclusion
- Non-English speakers
- The intervention will first be delivered in English to ensure feasibility with the content before adapting the material for patients who speak other languages.
- TKR was a result of a septic joint or revision (implant malfunction)
- Unable to exercise (e.g., bed bound or wheelchair bound)
- Have had contralateral TKR or other joint replacement surgery (hip, shoulder) within the past 5 years
- If they have RA or other connective tissue disease: Lupus, ankylosing spondylitis, psoriatic arthritis, scleroderma, infectious arthritis, polymyalgia rheumatica.
Key Trial Info
Start Date :
April 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT05217420
Start Date
April 5 2022
End Date
June 1 2026
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine Clinical & Translational Science Center
New York, New York, United States, 10065